Berger MG - Search Results

1

Efficiency of nilotinib to target chronic phase-chronic myeloid leukaemia primary mature CD34^- and immature CD34⁺ cells.

Berger MG, Lebecque B, Tassin T, Dannus LT, Berger J, Soucal M, Guerci A, Cony-Makhoul P, Johnson H, Etienne G, Guyotat D, Gagnieu MC, Pereira B, Saugues S, Tournilhac O, Hermet E, Bourgne C. Berger MG, et al. Among authors: berger j. Sci Rep. 2021 Mar 17;11(1):6187. doi: 10.1038/s41598-021-85734-0. Sci Rep. 2021. PMID: 33731863 Free PMC article.

2

Peripheral progenitor cells (CFU-GM, BFU-E, CD34) are increased in untreated chronic lymphocyte leukemia patients: stage B and C display a particularly high CD34+ cell count.

Berger M, Rapatel C, Boiret N, Halle P, Kanold J, Mareynat G, Tournilhac O, Albuisson E, Bonhomme J, Deméocq F, Travade P. Berger M, et al. Leuk Lymphoma. 1999 Nov;35(5-6):587-91. doi: 10.1080/10428199909169623. Leuk Lymphoma. 1999. PMID: 10609796

3

Granulocyte colony-stimulating factor alone at 20 micrograms/kg vs. 10 micrograms/kg for peripheral blood stem cell mobilization in children.

Halle P, Kanold J, Rapatel C, Boiret N, Berger M, Stephan JL, Albuisson E, Tournilhac O, Bonhomme J, Deméocq F. Halle P, et al. Pediatr Transplant. 2000 Nov;4(4):285-8. doi: 10.1034/j.1399-3046.2000.00128.x. Pediatr Transplant. 2000. PMID: 11079268 Clinical Trial.

4

Normal human bone marrow CD34(+)CD133(+) cells contain primitive cells able to produce different categories of colony-forming unit megakaryocytes in vitro.

Charrier S, Boiret N, Fouassier M, Berger J, Rapatel C, Pigeon P, Mareynat G, Bonhomme J, Camilleri L, Berger MG. Charrier S, et al. Among authors: berger j, berger mg. Exp Hematol. 2002 Sep;30(9):1051-60. doi: 10.1016/s0301-472x(02)00882-2. Exp Hematol. 2002. PMID: 12225797 Free article.

5

CD34+CDw90(Thy-1)+ subset colocated with mesenchymal progenitors in human normal bone marrow hematon units is enriched in colony-forming unit megakaryocytes and long-term culture-initiating cells.

Boiret N, Rapatel C, Boisgard S, Charrier S, Tchirkov A, Bresson C, Camilleri L, Berger J, Guillouard L, Guérin JJ, Pigeon P, Chassagne J, Berger MG. Boiret N, et al. Among authors: berger j, berger mg. Exp Hematol. 2003 Dec;31(12):1275-83. doi: 10.1016/j.exphem.2003.08.010. Exp Hematol. 2003. PMID: 14662335 Free article.

6

Effects of imiglucerase treatment on traumatic fracture and bone and blood abnormalities in a patient with previously untreated type 1 gaucher disease.

Boiret-Dupré N, Descamps S, Coudoré MA, Rapatel C, Kuentz M, Pereira S, Tournadre J, Berger J, Morell P, Berger MG. Boiret-Dupré N, et al. Among authors: berger j, berger mg. Clin Ther. 2009 Dec;31(12):2900-4. doi: 10.1016/j.clinthera.2009.12.001. Clin Ther. 2009. PMID: 20110029

7

Glucocerebrosidase deficiency dramatically impairs human bone marrow haematopoiesis in an in vitro model of Gaucher disease.

Berger J, Lecourt S, Vanneaux V, Rapatel C, Boisgard S, Caillaud C, Boiret-Dupré N, Chomienne C, Marolleau JP, Larghero J, Berger MG. Berger J, et al. Among authors: berger mg. Br J Haematol. 2010 Jul;150(1):93-101. doi: 10.1111/j.1365-2141.2010.08214.x. Epub 2010 May 9. Br J Haematol. 2010. PMID: 20507316 Free article.

8

The uptake of recombinant glucocerebrosidases by blood monocytes from type 1 Gaucher disease patients is variable.

Berger J, Stirnemann J, Bourgne C, Pereira B, Pigeon P, Heraoui D, Froissart R, Rapatel C, Rose C, Belmatoug N, Berger MG. Berger J, et al. Among authors: berger mg. Br J Haematol. 2012 Apr;157(2):274-7. doi: 10.1111/j.1365-2141.2011.08989.x. Epub 2012 Jan 9. Br J Haematol. 2012. PMID: 22224474 Free article. Clinical Trial. No abstract available.

9

Measurement of imatinib uptake by flow cytometry.

Bourgne C, Bamdad M, Janel A, Libert F, Gagnieu MC, Rapatel C, Pigeon P, Pereira S, Hermet E, Guerci A, Pereira B, Makhoul PC, Ansah AJ, Cahn JY, Guyotat D, Trouillier S, Berger J, Boiret-Dupré N, Berger MG. Bourgne C, et al. Among authors: berger j, berger mg. Cytometry A. 2012 Nov;81(11):996-1004. doi: 10.1002/cyto.a.22118. Epub 2012 Aug 28. Cytometry A. 2012. PMID: 22930640 Free article.

10

The chronic lymphocytic leukemia clone disrupts the bone marrow microenvironment.

Janel A, Dubois-Galopin F, Bourgne C, Berger J, Tarte K, Boiret-Dupré N, Boisgard S, Verrelle P, Déchelotte P, Tournilhac O, Berger MG. Janel A, et al. Among authors: berger j, berger mg. Stem Cells Dev. 2014 Dec 15;23(24):2972-82. doi: 10.1089/scd.2014.0229. Stem Cells Dev. 2014. PMID: 25055118

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

108 results

Search Page